{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T13:58:55Z","timestamp":1775311135445,"version":"3.50.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.pbb.2013.05.006","type":"journal-article","created":{"date-parts":[[2013,5,13]],"date-time":"2013-05-13T23:12:16Z","timestamp":1368486736000},"page":"91-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Antidepressant-like activity of 2-(4-phenylpiperazin-1-yl)-1, 8-naphthyridine-3-carboxylic acid (7a), a 5-HT3 receptor antagonist in behaviour based rodent models: Evidence for the involvement of serotonergic system"],"prefix":"10.1016","volume":"109","author":[{"given":"Baldev Kumar","family":"Gautam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankur","family":"Jindal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arghya Kusum","family":"Dhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radhakrishnan","family":"Mahesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2013.05.006_bb0005","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S1359-6446(05)03398-2","article-title":"Strategies for producing faster acting antidepressants","volume":"10","author":"Adell","year":"2005","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.pbb.2013.05.006_bb0010","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0022-3565(25)23184-6","article-title":"Serotonergic modulation of the release of endogenous norepinephrine from rat hypothalamic slices","volume":"256","author":"Blandina","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2013.05.006_bb0015","first-page":"212","article-title":"Action of caffeine on the spontaneous motility of the mouse","volume":"158","author":"Boissier","year":"1965","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/j.pbb.2013.05.006_bb0020","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00176837","article-title":"Is the forced swimming test a suitable model for revealing antidepressant activity?","volume":"94","author":"Borsini","year":"1988","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2013.05.006_bb0025","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1472-8206.1990.tb01016.x","article-title":"Is it possible to predict the activity of a new antidepressant in animals with simple psychopharmacological tests?","volume":"4","author":"Bourin","year":"1990","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.pbb.2013.05.006_bb0030","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.pbb.2006.09.003","article-title":"Acute treatment with 5-HT3 receptor antagonist, tropisetron, reduces immobility in intact female rats exposed to the forced swim test","volume":"85","author":"Bravo","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2013.05.006_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/YCO.0b013e3280117733","article-title":"Animal models of mood disorders: Recent developments","volume":"20","author":"Cryan","year":"2007","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.pbb.2013.05.006_bb0040","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.neubiorev.2005.03.008","article-title":"Assessing substrates underlying the behavioral effects of antidepressants using the modified rat Forced Swimming Test","volume":"9","author":"Cryan","year":"2005","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pbb.2013.05.006_bb0045","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s002130051131","article-title":"Murine models of depression","volume":"147","author":"Dalvi","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2013.05.006_bb0050","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1146\/annurev.psych.53.100901.135148","article-title":"Depression: perspectives from affective neuroscience","volume":"53","author":"Davidson","year":"2002","journal-title":"Annu Rev Psychol"},{"key":"10.1016\/j.pbb.2013.05.006_bb0055","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00004850-199112003-00002","article-title":"Depression and 5-HT","volume":"6","author":"Deakin","year":"1991","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pbb.2013.05.006_bb0060","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1734-1140(10)70263-2","article-title":"Effect of acute and chronic treatment with QCF-3 (4-benzylpiperazin-1-yl) (quinoxalin-2-yl) methanone, a novel 5-HT3 receptor antagonist, in animal models of depression","volume":"62","author":"Devadoss","year":"2010","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pbb.2013.05.006_bb0065","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1476-5381.1994.tb13140.x","article-title":"Effects of antidepressants on the inward current mediated by 5-HT3 receptors in rat nodose ganglion neurons","volume":"112","author":"Fan","year":"1994","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pbb.2013.05.006_bb0070","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0165-6147(93)90128-7","article-title":"Behavioural pharmacology of 5-HT, receptor antagonists: a critical uptake on therapeutic potential","volume":"14","author":"Greenshaw","year":"1992","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pbb.2013.05.006_bb0075","first-page":"171","article-title":"Clinical pharmacology of serotonin receptor type 3 (5-HT3) Antagonists","volume":"1","author":"Israili","year":"2001","journal-title":"Curr Med Chem - CNS Agents"},{"issue":"1\u20133","key":"10.1016\/j.pbb.2013.05.006_bb0080","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejphar.2012.05.051","article-title":"Antidepressant-like effect of etazolate, a cyclic nucleotide phosphodiesterase 4 inhibitor - an approach using rodent behavioral antidepressant tests battery","volume":"689","author":"Jindal","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2013.05.006_bb0085","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.brainresbull.2005.05.025","article-title":"Involvement of 5-HT1A receptors in the antidepressant-like effect of adenosine in the mouse forced swimming test","volume":"67","author":"Kaster","year":"2005","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pbb.2013.05.006_bb0090","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/0028-3908(94)90160-0","article-title":"The effect of tianeptine and sertraline in three animal models of depression","volume":"33","author":"Kelly","year":"1994","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2013.05.006_bb0095","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0163-7258(97)00004-1","article-title":"Olfactory bulbectomized rat as a model of depression: an update","volume":"74","author":"Kelly","year":"1997","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pbb.2013.05.006_bb0100","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0006-8993(93)91674-H","article-title":"5-HT3 receptors in the rat central nervous system are mainly located on nerve fibres and terminals","volume":"612","author":"Kidd","year":"1993","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2013.05.006_bb0105","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/330746a0","article-title":"Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding","volume":"330","author":"Kilpatrick","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2013.05.006_bb0110","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0022-3565(25)27497-3","article-title":"p-Chlorophenylalanine: a specific depletor of brain serotonin","volume":"154","author":"Koe","year":"1966","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.pbb.2013.05.006_bb0115","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.euroneuro.2005.10.001","article-title":"Effect of 5-HT3 receptor antagonist MDL 72222 on behaviours induced by ketamine in rats and mice","volume":"16","author":"Kos","year":"2006","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pbb.2013.05.006_bb0120","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/syn.890100402","article-title":"Quantitative autoradiographic mapping of 5-HT3 receptors in the rat CNS using [125I] iodo-zacopride and [3H] zacopride as radioligands","volume":"10","author":"Laporte","year":"1992","journal-title":"Synapse"},{"key":"10.1016\/j.pbb.2013.05.006_bb0125","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0074-7742(08)60295-0","article-title":"Anatomical, physiological, and behavioral aspects of olfactory bulbectomy in the rat","volume":"22","author":"Leonard","year":"1981","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.pbb.2013.05.006_bb0130","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.pnpbp.2009.03.004","article-title":"Antidepressant-like effect of the extract of Rosmarinus officinalis in mice: involvement of the monoaminergic system","volume":"33","author":"Machado","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pbb.2013.05.006_bb0135","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1016\/j.bmcl.2004.07.060","article-title":"Microwave assisted synthesis of 2-(4-substituted piperazin-1-yl)-1, 8-naphthyridine-3-carbonitrile as a new class of serotonin 5-HT3 receptor antagonists","volume":"14","author":"Mahesh","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pbb.2013.05.006_bb0140","first-page":"83","article-title":"Cancer chemotherapy induced nausea and vomiting: role of mediators, development of drugs and treatment methods","volume":"60","author":"Mahesh","year":"2005","journal-title":"Pharmazie"},{"key":"10.1016\/j.pbb.2013.05.006_bb0145","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.bbrc.2011.05.075","article-title":"Evaluation of anti- depressant-like activity of linezolid, anoxazolidinone class derivative -an investigation using behavioral tests battery of depression","volume":"409","author":"Mahesh","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pbb.2013.05.006_bb0150","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/87865","article-title":"The cellular neurobiology of depression","volume":"7","author":"Manji","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.pbb.2013.05.006_bb0155","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0278-5846(89)90061-4","article-title":"Effects of triiodothyronine (T3) on the potentiation by antidepressants of L-5-hydroxytryptophan-induced head-twitches in mice","volume":"13","author":"Martin","year":"1989","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pbb.2013.05.006_bb0160","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1476-5381.1992.tb14306.x","article-title":"Opposing roles for 5-HT1B and 5-HT3 receptors in the control of 5-HT release in rat hippocampus in vivo","volume":"106","author":"Martin","year":"1992","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pbb.2013.05.006_bb0165","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0022-3565(24)29416-7","article-title":"S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioural profile in comparison with venlafaxine, reboxetine, citalopram and clomipramine","volume":"298","author":"Millan","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2013.05.006_bb0170","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0014-2999(91)90770-Q","article-title":"Involvement of serotonergic neuronal systems in the anti-amnesic action of naftidrofuryl oxalate","volume":"205","author":"Nabeshima","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2013.05.006_bb0175","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0006-8993(97)01459-5","article-title":"The 5-HT3 receptor agonist attenuates the action of antidepressants in the forced swim test in rats","volume":"786","author":"Nakagawa","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2013.05.006_bb0180","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(02)00653-0","article-title":"Neurobiology of depression","volume":"34","author":"Nestler","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.pbb.2013.05.006_bb0185","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1211\/jpp.60.12.0010","article-title":"Depressant-like effects of Parthenolide in a rodents behavioural antidepressant test battery","volume":"60","author":"Pandey","year":"2008","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.pbb.2013.05.006_bb0190","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0165-6147(92)90119-Q","article-title":"Recent advances in the electrophysiological characterization of 5-HT3 receptors","volume":"13","author":"Peters","year":"1992","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pbb.2013.05.006_bb0195","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00213-004-2048-7","article-title":"Forced swimming test in mice: a review of antidepressant activity","volume":"177","author":"Petit-Demouliere","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2013.05.006_bb0200","first-page":"327","article-title":"Behavioural despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/j.pbb.2013.05.006_bb0205","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0014-2999(78)90414-4","article-title":"Behavioural despair in rats and mice: strain differences and the effects of imipramine","volume":"51","author":"Porsolt","year":"1978","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2013.05.006_bb0215","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1177\/0269881109348161","article-title":"The auspicious role of the 5-HT3 receptor in depression: a probable neuronal target?","volume":"24","author":"Rajkumar","year":"2010","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pbb.2013.05.006_bb0210","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/FBP.0b013e3282f3cfd4","article-title":"Antidepressant- like effects of serotonin type-3 antagonist, ondansetron: an investigation in behaviour-based rodent models","volume":"19","author":"Ramamoorthy","year":"2008","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pbb.2013.05.006_bb0220","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0091-3057(98)00181-6","article-title":"The determination of the optimal dose of milnacipran in the olfactory bulbectomized rat model of depression","volume":"62","author":"Redmond","year":"1999","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2013.05.006_bb0225","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0014-2999(97)00115-5","article-title":"Partial role of 5-HT2 and 5-HT3 receptors in the activity of antidepressants in the mouse forced swimming test","volume":"325","author":"Redrobe","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2013.05.006_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002130050638","article-title":"Dose dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity","volume":"138","author":"Redrobe","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2013.05.006_bb0235","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1177\/026988119801200404","article-title":"Psychopharmacological profile of the selective serotonin reuptake inhibitor, paroxetine:implication of noradrenergic and serotonergic mechanisms","volume":"12","author":"Redrobe","year":"1998","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pbb.2013.05.006_bb0240","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neubiorev.2005.03.010","article-title":"The olfactory bulbectomized rat as a model of depression","volume":"29","author":"Song","year":"2005","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pbb.2013.05.006_bb0245","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressant drugs","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2013.05.006_bb0250","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0928-0987(94)00065-4","article-title":"Lipophilicity and hydrogen-bonding capacity of H1-antihistaminic agents in relation to their central sedative side-effects","volume":"2","author":"Ter Laak","year":"1994","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"10.1016\/j.pbb.2013.05.006_bb0255","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1176\/appi.psy.42.3.258","article-title":"Possible serotonin syndrome in association with 5-HT3 Antagonist Agents","volume":"42","author":"Turkel","year":"2001","journal-title":"Psychosomatics"},{"key":"10.1016\/j.pbb.2013.05.006_bb0260","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0163-7258(90)90043-2","article-title":"Effects of psychotropic drugs on the behaviour and neurochemistry of olfactory bulbectomized rats","volume":"47","author":"Van Reizen","year":"1990","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pbb.2013.05.006_bb0265","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0014-2999(88)90825-4","article-title":"Localisation by autoradiography of neuronal 5-HT3 receptors in the mouse CNS","volume":"151","author":"Waeber","year":"1988","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2013.05.006_bb0270","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00008877-200205000-00001","article-title":"The validity of animal models of predisposition to depression","volume":"13","author":"Willner","year":"2002","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pbb.2013.05.006_bb0275","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/030097400446625","article-title":"Preclinical and clinical pharmacology of the 5-HT3 receptor Antagonists","volume":"29","author":"Wolf","year":"2000","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.pbb.2013.05.006_bb0280","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.brainres.2004.07.041","article-title":"Evidence for serotonin receptor subtypes involvement in agmatine antidepressant like-effect in the mouse forced swimming test","volume":"1023","author":"Zomkowski","year":"2004","journal-title":"Brain Res"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305713001226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305713001226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:32:03Z","timestamp":1758774723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305713001226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":56,"alternative-id":["S0091305713001226"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2013.05.006","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antidepressant-like activity of 2-(4-phenylpiperazin-1-yl)-1, 8-naphthyridine-3-carboxylic acid (7a), a 5-HT3 receptor antagonist in behaviour based rodent models: Evidence for the involvement of serotonergic system","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2013.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}